Corcept Therapeutics Incorporated Price to FCF Ratio 2006–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Corcept Therapeutics Incorporated (CORT): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 29.69.

From: 06/30/2018To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Corcept Therapeutics Incorporated Price to FCF Ratio — FAQ

Corcept Therapeutics Incorporated (CORT) price to fcf ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CORT's price to fcf ratio history?

The chart and table above show Corcept Therapeutics Incorporated's price to fcf ratio by year and by quarter, including the growth rate.